Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

PHASE2RecruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

October 13, 2025

Study Completion Date

October 13, 2025

Conditions

Malignancy

Interventions

DRUG

Al18F-PSMA-BCH PET/CT

Patients will be intravenously injected with Al18F-PSMA-BCH and undergo PET/CT scan.

Trial Locations (1)

RECRUITING

National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER